18.03.2016
- It’s official. Andrew Witty, CEO of Britain’s largest drugmaker, Glaxo SmithKline (GSK), has announced he will retire in March 2017 after nearly a decade at the helm. In a...
01.03.2016
- British drugmaker GlaxoSmithKline is said to have launched a search for a new CEO to replace Andrew Witty, who is now widely expected to step down at the latest by the end of 2017...
